These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Aggravation of Parkinson's disease by cinnarizine. Martí Massó JF; Obeso JA; Carrera N; Martínez-Lage JM J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):804-5. PubMed ID: 3302112 [TBL] [Abstract][Full Text] [Related]
5. Impotence associated with cinnarizine. Sempere AP; Garcia FM; Duarte J; Mataix AL; Coria F; Claveria LE Ann Pharmacother; 1993 Mar; 27(3):370. PubMed ID: 8453180 [No Abstract] [Full Text] [Related]
6. [Parkinsonism possibly caused by cinnarizine]. Martí Massó JF; Carrera N; de la Puente E Med Clin (Barc); 1985 Nov; 85(15):614-6. PubMed ID: 4079549 [No Abstract] [Full Text] [Related]
7. Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy. Toll A; Campo-Pisa P; González-Castro J; Campo-Voegeli A; Azón A; Iranzo P; Lecha M; Herrero C Lupus; 1998; 7(5):364-6. PubMed ID: 9696142 [TBL] [Abstract][Full Text] [Related]
8. Weight gain associated with cinnarizine. Navarro-Badenes J; Martínez-Mir I; Palop V; Rubio E; Morales-Olivas FJ Ann Pharmacother; 1992; 26(7-8):928-30. PubMed ID: 1504403 [TBL] [Abstract][Full Text] [Related]
10. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine. Capellà D; Laporte JR; Castel JM; Tristán C; Cos A; Morales-Olivas FJ BMJ; 1988 Sep; 297(6650):722-3. PubMed ID: 3147743 [No Abstract] [Full Text] [Related]
11. [Cinnarizine and Parkinson disease]. Micheli F; Fernández Pardal M; Paradiso G; Pikielny R Neurologia; 1987; 2(4):194-5. PubMed ID: 3274129 [No Abstract] [Full Text] [Related]
12. Cinnarizine-induced parkinsonism: ten years later. Martí-Massó JF; Poza JJ Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736 [TBL] [Abstract][Full Text] [Related]
13. Movement disorders and depression due to flunarizine and cinnarizine. Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706 [TBL] [Abstract][Full Text] [Related]
14. Intermittent claudication: a controlled study in parallel time of the short-term and long-term effects of cinnarizine. Barber JH; Reuter CA; Jageneau AH; Loots W Pharmatherapeutica; 1980; 2(6):401-7. PubMed ID: 7433479 [TBL] [Abstract][Full Text] [Related]
15. Cinnarizine-induced parkinsonism: ten years later. Negrotti A; Calzetti S Mov Disord; 1999 May; 14(3):534-5. PubMed ID: 10348490 [No Abstract] [Full Text] [Related]
16. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine). Kalimo K; Jansen CT Ann Allergy; 1980 Jan; 44(1):34-7. PubMed ID: 7352689 [TBL] [Abstract][Full Text] [Related]
18. Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study. Lin HL; Lin HC; Tseng YF; Chen SC; Hsu CY Eur J Clin Pharmacol; 2017 Mar; 73(3):365-371. PubMed ID: 27986997 [TBL] [Abstract][Full Text] [Related]
19. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine. Miguel R; Correia AS; Bugalho P J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483 [TBL] [Abstract][Full Text] [Related]
20. Controlled clinical trial of pentoxifylline versus cinnarizine in the treatment of labyrinthine disorders. Ganança MM; Mangabeira Albernaz PL; Caovilla HH; Ito YI Pharmatherapeutica; 1988; 5(3):170-6. PubMed ID: 3283777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]